I 118th CONGRESS 2d Session H. R. 7383 IN THE HOUSE OF REPRESENTATIVES February 15, 2024 Ms. Matsui (for herself and Mr. Bilirakis ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.